Discover how to navigate the complex process of rescuing a clinical trial with Ergomed’s Regulatory Dashboard on study transitions.
This whitepaper is a must-read for biotech and pharma companies seeking to change CRO partners mid-study to protect critical milestones and maintain regulatory compliance. Learn the essential steps and risk management strategies to ensure a seamless transfer of regulatory responsibilities, with a focus on minimizing disruptions and safeguarding data integrity.
Author
Marcelina Rybianska
Regulatory Affairs Director, Strategy